Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muriaux, D.
Right arrow Articles by Paoletti, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muriaux, D.
Right arrow Articles by Paoletti, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 52, Issue of December 27, 1996 pp. 33686-33692
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

NCp7 Activates HIV-1Lai RNA Dimerization by Converting a Transient Loop-Loop Complex into a Stable Dimer*

(Received for publication, May 28, 1996, and in revised form, September 18, 1996)

Delphine Muriaux Dagger , Hugues De Rocquigny §, Bernard-Pierre Roques § and Jacques Paoletti

From Unité de Biochimie, URA 147 CNRS, 39 rue Camille Desmoulins, Institut Gustave Roussy, 94805 Villejuif, France and § Département de Pharmacochimie Moléculaire et Structurale, U266 INSERM, URA D1500 CNRS, Université René Descartes, 4 avenue de l'Observatoire, 75006 Paris, France

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Nucleocapsid protein 7 (NCp7), the human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein, was shown to strongly potentiate the dimerization of the retroviral genomic RNA. This process involves the interaction of two retroviral RNA monomer subunits near their 5'-ends. A region located upstream from the splice donor site was recently identified as being responsible for the formation of dimeric HIV-1 RNA. This region appeared to be confined within a stem-loop structure, with an autocomplementary sequence in the loop. In an in vitro study of spontaneous dimer formation, we reported that the 77-402 RNA transcript forms two distinct dimers differing in their thermostability: D37 and D55. We identified D37 as a "kissing" complex structure, formed via a loop-loop interaction between the two monomers, and D55 as a double stranded structure involving all nucleotides of the stem-loop via canonical base pairing. In this report, we have characterized the role of NCp7 in the HIV-1Lai RNA dimerization process by using in vitro dimerization assays with RNA transcripts of different lengths and dimer thermal dissociation. Our results show that the nucleocapsid protein NCp7 activates RNA dimerization very likely through interaction with the kissing complex and converts it into a stable dimer. Furthermore, this NCp7-promoted conversion only occurs if the 240-280 stem-loop structure is present in HIV-1Lai RNA molecules and contains the autocomplementary G257CGCGC262 sequence. This study suggests that, under physiological conditions, an NCp7-mediated RNA conformational change is involved in the maturation of the HIV-1 RNA dimer.


INTRODUCTION

Retrovirus virions carry a diploid genome consisting of an RNA complex formed by the association of two identical unspliced viral RNA molecules (1). In mature virions, RNA molecules are tightly associated with viral finger protein molecules, nucleocapsid proteins (NCps)1 (2, 3). Retroviral NCp is generated once the gag gene product, the structural Pr55gag protein, has been processed by the viral protease (4) and is highly conserved among all known retroviruses (5).

The HIV-1 NC protein (NCp7) is a small basic protein with two zinc fingers of the CX2CX4HX4C form, flanked by regions rich in basic residues (5). Zinc fingers were found to bind zinc with high affinity (6) through a tetracoordinated complex involving the three cysteine residues and the histidine residue (7). Nuclear magnetic resonance revealed the three-dimensional structure of NCp7 (8, 9), and the zinc motifs were found to be in close proximity due to the presence of the histidine residue and to the conformation of the basic linker 29RAPRKKG35 (10, 11, 12). Point mutation of the conserved cysteine and histidine residues resulted in a drastic reduction of genomic RNA packaging (13, 14, 15). Moreover, mutation affecting NCp7 folding impairs the co-assembly of Gag and Gag-pol precursors (10, 16) as well as the protection of genomic RNA (11), and this results in a drastic decrease in viral infectivity.

In vivo, NCp7 was shown to interact, at the 5'-end of genomic RNA, with a sequence referred to as the psi  sequence, located by directed mutagenesis between the primer binding site (PBS) and AUG of the gag gene (14). Chimeric viruses containing a nonhomologous psi  sequence and an NC-coding gene were noninfectious, suggesting a highly specific recognition process (17).

Previous works have reported in vitro studies on NCp7 and have revealed its nucleic acid binding---especially to the psi  sequence (18)---and annealing activities (2, 19, 20, 21, 22, 23, 24, 25, 26). NCp binds preferentially to single-stranded nucleic acids with a high affinity for viral RNA (1). Thus, NCp seems to play a key role in several steps of the viral life cycle. During reverse transcription, NCp stimulates tRNA primer annealing to the PBS at the 5' end of the viral RNA (19, 20, 21) and also participates in the initial strand transfer event required for long terminal repeat synthesis (22, 23, 24). NC protein has also been shown to activate retroviral HIV-1 RNA dimerization in vitro (2, 21, 27), which results in the formation of the dimer linkage structure. The dimer linkage structure, defined by electron microscopy, is an RNA-RNA interaction site located in the psi  sequence close to the 5'-ends of viral RNA molecules (28, 29). The nature of the base-pairing interactions of the dimer linkage structure has been studied by analyzing spontaneous RNA transcript dimerization in vitro (2, 27). Primary results were in favor of the hypothesis that HIV-1 RNA dimerization involves purine-rich sequences, which should form noncanonical base pairs (30, 31, 32). However, additional studies indicated that such sequences are dispensable for RNA dimerization of HIV-2 (33), HIV-1 (34, 35), and Moloney murine leukemia virus (36). Another model was thus proposed to explain the dimerization process of viral RNA. HIV-1 (35, 37, 38, 39), Moloney murine leukemia virus (36), and avian leukosis virus2 RNA transcripts, which contain an autocomplementary sequence in a stem-loop structure, located downstream from the PBS and upstream from the splice donor site, are able to dimerize spontaneously in vitro. It has been proposed that HIV-1 RNA dimer formation is initiated by the annealing of these autocomplementary sequences via a loop-loop interaction between the two RNA molecules, resulting in the formation of a "kissing" complex at 37 °C (39). This intermediary complex should spontaneously evolve at 55 °C toward a more stable dimer involving all the nucleotides of the stem-loop structure in canonical base pairs (39). However, the role of the NC protein in this process has not yet been investigated. The ability of the NC protein to destabilize nucleic acid structures (41) and to promote nucleic acid annealing and renaturation (42) should be taken into account when explaining RNA dimerization in the presence of the protein. In this report, we analyze the role of a synthetic NCp7 in the in vitro dimerization process of HIV-1Lai RNA transcripts.


MATERIALS AND METHODS

Molecular Clones

Details of the pDM2, pDM3, pDM6, and pDM7 plasmid constructions are given elsewhere (35).

RNA Transcripts 77-402, 224-402, 224-296, 296-402, and 224-402DEL

HaeIII and RsaI restriction enzymes were obtained from New England Biolabs. The pDM3 plasmid was digested by HaeIII and transcribed by T7 RNA polymerase and gave rise to a transcript starting from position 77 of the genomic HIV-1Lai RNA sequence and ending at position 402. This transcript will be referred to as RNA 77-402 (Fig. 5).


Fig. 5. Effect of the NCp7 protein on in vitro dimerization of shorter HIV-1Lai RNA transcripts. A, Representation of the 5'-end of HIV-1Lai genomic RNA. TAR, trans-activating responsive element; PBS, primer tRNALys3 binding site; sd, splice donor site; and AUG, initiation codon for Pr55gag synthesis. psi  HIV-1*, 5'-packaging signal of HIV-1 recently described by Clever et al. (40). Numbering is in relation to the genomic RNA cap site (+1). The restriction sites of interest are indicated: HindIII (+77), SacI (+224), RsaI (+296), and HaeIII (+402). B, HIV-1Lai RNA transcripts used in this study. RNA transcripts presented here were generated in vitro as described under "Materials and Methods." RNA dimer columns, levels of dimeric RNA produced in NC buffer at 37 °C for 15 min in the absence (-) or presence (+NCp7) of the NCp7 protein after SDS-phenol treatment. -, 0-5%; +/-, 10-20%; ++, 60-70%; +++, 100%. (mean values from at least three experiments). C, agarose gel electrophoresis of shorter HIV-1Lai RNA transcripts. The RNAs are numbered as in B. Heat-denatured RNAs were incubated in the NC buffer in the absence (-) or presence (+) of NCp7 for 15 min at 37 °C. The NCp7/RNA ratio is 20. All samples were submitted to SDS-phenol treatment as described under "Materials and Methods" before being analyzed on the gel. Lane M, monomeric form of RNAs.
[View Larger Version of this Image (18K GIF file)]


The pDM2 plasmid was digested by either HaeIII or RsaI and transcribed by T7 RNA polymerase and gave rise to transcripts starting from position 224 of the genomic HIV-1Lai RNA sequence and ending at positions 402 and 296, respectively. These transcripts will be referred to as RNA 224-402 and RNA 224-296 transcripts (Fig. 5).

The pDM6 plasmid was digested by HaeIII and transcribed by T7 RNA polymerase and gave rise to transcripts starting from position 296 of the genomic HIV-1Lai RNA sequence and ending at positions 402. This transcript will be referred to as RNA 296-402 (Fig. 5).

The pDM7 plasmid, first digested by HaeIII, was transcribed with T7 RNA polymerase and gave rise to RNA transcript 224-402DEL, devoid of nucleotides 257-266 (Fig. 5).

In Vitro RNA Synthesis and Purification

Experimental procedures for the HIV-1Lai RNA transcript production and purification are given elsewhere (35, 39).

Synthetic Nucleocapsid Protein

Solid phase synthesis of HIV-1 NCp7 protein, consisting of 72 amino acids, was performed as described previously (43).

Stock solutions of NCp7 were conserved at 10-3 M and 4 °C in Milli-Q water (Millipore) containing three equivalent molar concentrations of ZnSO4.

HIV-1 RNA Transcript Dimerization Assays in the Presence of the NCp7

In a standard dimerization assay, RNA in 14 µl of Milli-Q water was heated for 2 min at 90 °C, chilled on ice for 2 min, and adjusted to 20 µl with 4 µl of 5 × NC buffer containing 100 mM Tris-HCl, pH 7.5, 250 mM NaCl, 25 mM dithiothreitol, and 1 mM MgCl2 and 2 µl of 10 × NCp7 solution, i.e. 17.5 protein molecules/RNA strand, (or poly-L-lysine) or polyethylene glycol 8000 or 2 µl of Milli-Q water). Poly-L-lysine and polyethylene glycol 8000 were purchased from Sigma.

The samples were incubated for 15 min at 37 °C or at temperatures ranging from 10 to 60 °C. At the end of incubation, all the samples were cooled on ice for 2 min, placed for 2 min at room temperature, and then mixed with 10 µl of water and 3 µl of 5% SDS for 5 more min at room temperature. The RNA transcripts were phenol extracted for deproteinization with 30 µl of phenol saturated by 40 mM Tris-HCl, pH 6.5, 0.1% SDS, and 2.5 mM EDTA. Three µl of loading buffer (50% (w/v) glycerol and 0.025% (w/v) tracking dyes) were then added, and the samples were loaded on a 1.5% Sea Kem agarose gel and electrophoresed at 5 V/cm and 4 °C in buffer containing 50 mM Tris-borate, pH 8.3, 1 mM EDTA, and 0.2 µg/ml ethidium bromide. Monomeric RNA transcripts were obtained at 20 °C in a buffer containing 10 mM Tris-HCl, pH 7.5.

Melting Temperature (Tm) Determination of Dimer Dissociation

After denaturation at 90 °C for 2 min in nuclease-free water, the RNA was incubated in a buffer containing 50 mM Tris-HCl, pH 7.5, and 100 mM NaCl (dimer buffer) at a strand concentration of 0.8 µM at either 37 °C or 55 °C for 90 min for optimal dimerization (35). The resulting dimers, D37 (unstable dimer) and D55 (stable dimer), were then dialyzed (Millipore V6 filters, 0.025 µm) for 2 h at 4 °C against 1 × NC buffer containing 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM dithiothreitol, and 0.2 mM MgCl2. Unstable dimer was then incubated in the presence of NCp7 (i.e. 1 molecule of the protein per 20 nt of RNA 77-402) for 15 min at 37 °C. Both dimers were then treated with SDS-phenol, as described above, for deproteinization, and 20-µl aliquots of each sample were then incubated for 5 min at varying temperatures ranging from 10 to 65 °C and electrophoresed as described above. After fluorescent scanning of the gels using a Bioprofil apparatus (Vildber Lourmat, Marne La Vallee, France), the percentage of dimer and monomer was estimated. The percentage of the dimer was defined as the area of the dimer peak divided by the sum of the areas of monomer and dimer peaks. The Tm was estimated from the plot of the amount of the dimer as a function of temperature.

Antisense DNA Oligonucleotide Experiments

Purified synthetic DNA oligonucleotides complementary to positions 251-267 of the HIV-1Lai sequence (oligonucleotide 257B, 5'-GCCGTGCGCGCTTCAGC3-') and to positions 268-284 of the HIV-1Mal sequence (35, 39) (oligonucleotide 257 M, used as a control oligonucleotide, differs from 257B by 4 nt, 5'GC<UNL>T</UNL>GTG<UNL>T</UNL>GC<UNL>A</UNL>C<UNL>C</UNL>TCAGC3') were obtained from Genosys, Inc. Numbering is relative to the genomic RNA cap site (+1).

DNA oligonucleotides were 5'-32P-labeled with [gamma -32P]ATP (Amersham, Corp.) and T4 polynucleotide kinase (Boehringer Mannheim). The specific radioactivity was about 105 cpm/µg DNA oligonucleotide.

RNA 77-402 was heat-denatured in the presence of the 32P-DNA oligonucleotide before starting the in vitro dimerization process. NCp7 was then added with the NC buffer as described above. After a SDS-phenol treatment, 32P-DNA oligonucleotide-RNA complexes were analyzed by 1.5% agarose gel electrophoresis. After staining with ethidium bromide and photography, the gel was fixed for 10 min in 10% trichloroacetic and dried for 40 min under vacuum at room temperature. Hybridization of the 32P-DNA oligonucleotide to monomeric and dimeric RNA 77-402 was detected by autoradiography of the corresponding gel.

RNA Secondary Structure Analysis

RNA secondary structures were predicted with the MFOLD program, which uses the energy minimization method of Zucker (44) and energy rules developed by Turner et al. (45).

The secondary structure of the HIV-1Lai 240-280 region within the RNA 77-402 transcript was confirmed by enzymatic probing (39).


RESULTS

NCp7 Activates HIV-1Lai RNA 77-402 Dimerization

In vitro dimerization of the HIV-1Lai RNA 77-402 transcript was performed in the presence of varying amounts of NCp7. After dimerization, the dimer was deproteinized and analyzed by agarose gel electrophoresis. Fig. 1A shows that although the RNA 77-402 transcript incubated alone migrates mainly as a monomer (lane D, around 15-20% of dimer), in the presence of NCp7, the monomer disappears to give rise to a RNA dimer together with a small amount of higher order multimers (lanes 1/20, 1/10, 1/5, and 1/2). It should be noted, for purposes of comparison, that the dimer samples obtained in the presence or absence of the protein were submitted to the same deproteinization step. Under these conditions, NCp7 activates RNA 77-402 dimerization, and this activation is almost complete for an NCp7 to RNA ratio of at least 1 NCp7 molecule/20 nt (Fig. 1A, lane 1/20). This result is in accordance with several previous works in which retroviral NC was found to activate retroviral RNA dimerization in vitro (2, 21, 27).


Fig. 1. HIV-1Lai RNA 77-402 dimerization is specifically activated by NCp7. A, heat-denatured RNAs were incubated in the NC buffer at 37 °C in the absence (lane D) or presence of 1 molecule of NCp7/50, 20, 10, 5, or 2 nt of RNA 77-402. B, heat-denatured RNAs were incubated in the NC buffer at 37 °C in the absence (lane D) or presence of 1 molecule of poly-L-lysine (PolyLYS)/20, 10, or 5 nt of RNA 77-402 or 1-10% of polyethylene glycol 8000 (PEG8000) in the samples. RNA 77-402 can be seen in a monomeric form at 20 °C in a buffer containing 10 mM Tris-HCl, pH 7.5 (lanes M). Samples, after treatment with SDS-phenol, were analyzed by ethidium bromide-stained 1.5% agarose gel electrophoresis. Monomer, dimer, and multimers of RNA 77-402 are indicated.
[View Larger Version of this Image (29K GIF file)]


The specificity of this activation process was tested by using poly-L-lysine instead of NCp7 in the same dimerization assay. This peptide, a highly basic polypeptide, was unable to activate RNA 77-402 dimerization efficiently (Fig. 1B, lanes 1/20, 1/10, and 1/5); the percentage of dimer remained the same as in the RNA control (Fig. 1B, lane D). However, multimers were induced by poly-L-lysine (Fig. 1B, lanes 1/20, 1/10, and 1/5). This could result from electrostatic binding of the basic polypeptides to the RNA molecules. In the case of NCp7, at ratios higher than 1/50 protein/nt, such a multimerization occurs (Fig. 1A, lanes 1/20, 1/10, 1/5, and 1/2), but we observed a difference between the migration of the multimers formed in the presence of NCp7 and the migration of those formed in the presence of poly-L-lysine. This difference could be due to the fact that in the presence of poly-L-lysine, we observed an aggregation process leading to trimers, tetramers, pentamers, etc., whereas in the presence of NCp7, the multimers seem to correspond to multimerization of dimers leading to tetramers and even higher order structures, i.e. hexamers and octamers. Also, we observed a decrease of multimer content (at least from ratio 1/20 to 1/5; Fig. 1A), which may be due to the fact that as the concentration of NCp7 increases, the protein coats the RNA, and the interaction between RNA molecules may not be as efficient. We also tested the influence of polyethylene glycol on the dimerization process, since polyethylene glycol is known to enhance the rate of hybridization of nucleic acids (46). Increasing amounts of polyethylene glycol did not have a detectable effect on RNA 77-402 dimerization (Fig. 1B, lanes 1, 5, and 10%).

To characterize further the dimerization process, the kinetics of RNA 77-402 dimerization were investigated (data not shown). In the presence of NCp7, dimerization was complete after 5 min at 37 °C, and no kinetic profile was observed whatever the protein concentration. These results are in accordance with those presented by Darlix and co-workers (2) with the NCp15 protein and indicate that NCp7 probably does not function in a catalytic manner.

Effect of the NCp7 on the Dimerization Process as a Function of the Temperature

We analyzed the effect of the temperature on spontaneous in vitro dimerization of HIV-1Lai RNA 77-402 (Fig. 2A). On incubation in the NC buffer, spontaneous dimerization of RNA 77-402 occurred. Up to 37 °C, about 60% of the RNA was dimeric (Fig. 2A, lanes 20, 30, and 37), whereas between 45 and 50 °C, this dimer dissociated (Fig. 2A, lanes 45 and 50). This dissociation led to the formation of two monomeric conformers (m and m'), the nature of which remains unknown. For temperatures higher than 50 °C, some dimer reappeared when m' disappeared (Fig. 2A, lanes 55 and 60). The same results were observed in dimer buffer while characterizing the spontaneous in vitro RNA 77-402 dimerization process (39), and, as previously shown, one of these dimers, formed at 37 °C, was termed D37 and identified as an unstable kissing complex, resulting from the loop-loop interaction of the autocomplementary G257CGCGC262 sequence. The other dimer, formed at 55 °C, was termed D55 and corresponded to a more stable double-stranded structure.


Fig. 2. RNA 77-402 dimer formation with or without NCp7 as a function of temperature. Experimental conditions are 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM dithiothreitol, 0.2 mM MgCl2, and 1 molecule of NCp7/20 nt of RNA. The total RNA strand concentration is 0.8 µM. d, dimer; m, monomer; m', monomer that migrates differently in the gel. Heat-denatured RNAs were incubated in the NC buffer at temperatures between 10 and 60 °C, without any protein (A and B) or in the presence of NCp7 (C) for 15 min. Samples, untreated by SDS-phenol (A) or after treatment with SDS-phenol (B and C), were analyzed by ethidium bromide-stained 1.5% agarose gel electrophoresis.
[View Larger Version of this Image (57K GIF file)]


Samples required SDS-phenol treatment, before gel analysis, in the presence of the NCp7 protein. Thus, RNA 77-402 dimerization was investigated as a function of the temperature in the absence of NCp7 but in NC buffer followed by SDS-phenol treatment (Fig. 2B). Under these conditions, dimerization, observed without SDS-phenol treatment between 20 and 37 °C (Fig. 2A), no longer occurred (Fig. 2B, lanes 20 and 37). This suggests that the kissing complex was not stable enough to resist such treatment and that only the dimer formed at 55 °C was stable enough to remain intact (Fig. 2B, lanes 55 and 60).

Then, the experiment was performed in the presence of the NCp7 nucleocapsid protein to observe the effect of this protein on dimer formation (Fig. 2C). NCp7 promoted complete RNA 77-402 dimerization at temperatures ranging from 30 to 60 °C (Fig. 2C). Dimer instability, triggered with SDS-phenol treatment (Fig. 2B) and occurring in the 45-50 °C range (Fig. 2A), had disappeared in the presence of the protein (Fig. 2C). This could signify that NCp7 promotes the formation of a unique dimer able to support deproteinization (Fig. 2C, lanes 20-60) and strongly suggests that the dimer formed in the presence of NCp7 is the same as the one observed at 55 °C in its absence. We were eager to check whether NCp7 was capable of converting the unstable kissing complex into the stable dimer.

NCp7 Converts an Unstable Dimer into a Stable One

The thermal stability of the dimer formed at 55 °C, in the absence of the protein, was compared with that of the kissing complex submitted to NCp7 activity (Fig. 3). The unstable dimer, D37, and the stable dimer, D55, were formed in the dimer buffer and then dialyzed against the NC buffer so that experiments in the presence of the protein could be performed. The unstable dimer, D37, was incubated with NCp7 for 15 min at 37 °C, but not the stable one. Both dimers were then submitted to deproteinization by SDS-phenol treatment before the thermal denaturation experiment. Agarose gels corresponding to these experiments are shown (Fig. 3A) together with the denaturation curves (Fig. 3B). Interestingly enough, both dimers had the same Tm value of 35-36 °C in NC buffer after SDS-phenol treatment, whereas the kissing complex formed at 37 °C under the same conditions without NCp7 had disappeared (Fig. 2B, lane 37). These results show that both dimers have the same stability and therefore are likely the same. It is noteworthy that the temperature obtained for the Tm value was low (35-36 °C) compared with the temperature value required for the formation of the stable dimer (55 °C). This difference was certainly due to the presence of residual phenol in the samples after SDS-phenol treatment just before conducting the thermal denaturation experiment, since phenol is known to have an effect on the stability of double stranded DNA (47) or retroviral RNA (48), by decreasing the Tm value.


Fig. 3. Thermal stability of the RNA 77-402 dimer formed either at 37 °C in the presence of the NCp7 or at 55 °C in the absence of the NCp7. After in vitro RNA 77-402 dimerization in the dimer buffer at either 37 or 55 °C, the unstable and stable dimers were dialyzed against NC buffer. The unstable one was incubated with the protein (1 molecule of NCp7/20 nt) for 15 min at 37 °C, whereas the other was not. The two resulting dimers were then submitted to SDS-phenol treatment, and aliquots of each were incubated 5 min at the indicated temperatures. Samples were analyzed by 1.5% agarose gel electrophoresis, and the percent of each species was determined from the gel. The temperatures on the plot correspond to the temperatures shown above the gels. d, dimer; m, monomer.
[View Larger Version of this Image (22K GIF file)]


Inhibition of HIV-1Lai RNA 77-402 Dimerization by an Oligomer in the Presence of the NCp7 Protein

We previously defined a complementary DNA oligonucleotide, oligomer 257B, which targets the HIV-1Lai sequence 257-262 containing nucleotides G257CGCGC262 and totally inhibits the dimerization process of the two RNA 77-402 dimers (D37 and D55) at an oligonucleotide 257B/RNA ratio of 1/1 (39). We used this oligonucleotide to interfere with the dimerization process of RNA 77-402 mediated by NCp7 (Fig. 4). Total inhibition of dimerization was observed for RNA 77-402 dimer, at an oligonucleotide 257B/RNA ratio of 1/1, at 37 °C in the presence of the NCp7 protein (Fig. 4A, lane 257B), whereas oligomer 257M, used as a control, was unable to prevent dimer formation of RNA 77-402 (Fig. 4A, lane 257M). Moreover, we checked that oligomer 257B was only hybridizing to RNA 77-402 in its monomeric form (Fig. 4B, lane 257B) and that oligomer 257M was not (Fig. 4B, lane 257M).


Fig. 4. Inhibition of HIV-1Lai RNA 77-402 dimer formation by oligonucleotide 257B in the presence of NCp7. RNA 77-402 (0.8 µM) was incubated in NC buffer with 1 molecule of NCp7/20 nt for 15 min at 37 °C in the absence (lane 0) or presence of 1 molar equivalent of 32P-DNA oligonucleotide 257B (lane 257B) or 32P-DNA oligonucleotide 257M (lane 257M) (see "Materials and Methods"). Lane M, monomeric form of RNA 77-402; lane D, RNA 77-402 in the NC buffer without any protein; lane MK, 0.16-1.77-kilobase RNA ladder (Life Technologies, Inc.). m and d, and dimeric RNAs, respectively. A, 1.5% agarose gel electrophoresis. B, autoradiogram of A.
[View Larger Version of this Image (31K GIF file)]


These experiments allow us to conclude that the same autocomplementary sequence in stem-loop structure 240-280 is involved in dimerization both in the presence and in the absence of NCp7 (35, 39).

Dimerization of Short HIV-1Lai RNA Transcripts with NCp7

Previously used RNA transcripts (35) were tested for their ability to dimerize in the absence or presence of NCp7, at 37 °C, in the NC buffer (Fig. 5).

RNA transcripts 224-402 and 224-296, containing the stem-loop structure 240-280, spontaneously dimerized at 60-70% in the NC buffer (Fig. 5C, -) and completely in the presence of NCp7 (Fig. 5C, +). In contrast, RNA 224-402DEL, devoid of the G257CGCGCACGG266 sequence (Fig. 5B, RNA 224-402 DEL), was unable to dimerize significantly in the absence of the protein (Fig. 5C, -) and also in its presence (Fig. 5C, +). It is noteworthy that the 10-nucleotide deletion did not alter the overall secondary structure of the molecule despite a modification in the primary sequence of the stem-loop, which was no longer autocomplementary (35). We also found that RNA 296-402 (Fig. 5B), which contains four polypurine tracts, was unable to dimerize significantly in the absence or presence of NCp7 (Fig. 5C- and +).

We therefore conclude that the autocomplementary G257CGCGC262 sequence in stem-loop structure 240-280 (Fig. 6, Monomer) is necessary for HIV-1Lai RNA dimer formation in the presence of NCp7, as described under conditions without the protein (35).


Fig. 6. Model of NCp7 implication on dimerization process of HIV-1Lai RNA in vitro.
[View Larger Version of this Image (19K GIF file)]



DISCUSSION

This work aimed at elucidating the role of NCp7 in the in vitro dimerization process of HIV-1Lai RNA. We have previously proposed a model of spontaneous in vitro dimerization of transcript RNA 77-402 under conditions of low ionic strength (39). This model, which has been confirmed by another recent study (49), suggests the formation of a kissing complex at 37 °C, which is converted into a stable dimer only if the temperature is increased to 55 °C. Those two entities, D37 and D55, are involved in HIV-1Lai RNA dimer formation, and we have proposed NCp7 as the trigger provoking the conformational change that causes the kissing complex to be transformed at 37 °C into the stable double stranded dimer (Fig. 6).

We report here that NCp7 was capable of activating RNA 77-402 transcript dimerization (Fig. 1), within a 20 to 60 °C range, at 50 mM NaCl, pH 7.5 (Fig. 2C). These results confirm that NC protein from HIV-1 activates HIV-1 RNA dimerization in vitro (2, 21) at NC/RNA ratios equal to or higher than 1/50. When the NC/RNA ratio reaches 1/20, NCp7-promoted dimerization is complete (Fig. 1A). The fact that NCp7 was inactive at temperatures lower than 20 °C (Fig. 2C, lanes 10 and 20) could be due to the very strong stability of the stems in the kissing complex, suggesting that the protein would be incapable of destabilizing these stems at temperatures lower than 20 °C.

More important is the finding that, at 37 °C, NCp7 is able to convert the unstable dimer, corresponding to the kissing complex previously described (39), into a stable dimer (Fig. 3), the stability of which corresponds to that of D55. This suggests that NCp7 interacts with the kissing complex to allow this conversion, which does not spontaneously occur at 37 °C without the protein. The recognition of such a loop-loop complex by NCp7 is a process comparable with that found in the Rom protein. This bacterial protein facilitates sense-antisense RNA pairing by binding to the transiently formed hairpin pairs of RNA I and complementary RNA II (50, 51).

NCp7-dependent dimerization of HIV-1 RNA has already been investigated. Sakagushi et al. (27) described a specific nucleotide region required for NCp7 binding and RNA dimerization, which is the same as the one previously described by Darlix et al. (2). However, the model proposed by Sakagushi et al. (27) is not in accordance with the data presented here, since RNA 296-402, which corresponds to RNA 311-415 of HIV-1Mal described by Darlix et al. (2) and which contains the 44-nt RNA described by Sakagushi et al. (27), is unable to dimerize significantly with or without NCp7 (Fig. 5). In contrast, dimerization mediated by NCp7 of HIV-1Mal RNA 1-415, described by De Rocquigny et al. (21), is in accordance with our results. This RNA transcript contains the entire sequence of the corresponding HIV-1Lai RNA 77-402 transcript.

We found that the autocomplementary G257CGCGC262 sequence in stem-loop structure 240-280 (Fig. 6, Monomer) is necessary for HIV-1Lai RNA dimer formation in the presence of NCp7 (Fig. 5), and that NCp7 is able to promote RNA 77-402 dimerization at 50 °C, whereas in the absence of the protein, no dimer is found (Fig. 2). Because the RNA annealing between the two monomers happens spontaneously without NCp7 (Fig. 2A), these results are more in favor of a specific action of NCp7 on the kissing complex to convert it into a stable dimer rather than in promoting the loop-loop interaction driven by the GCGCGC sequence and the stem-loop structure of the RNA molecule. However, considering our results, we cannot definitively exclude that Ncp7 might promote the formation of the stable dimer directly from the monomer (Fig. 6, Monomer right-arrow D55). To determine whether NCp7 would specifically recognize the 240-280 stem-loop structure, we tried to identify a site on the protein exhibiting a high affinity for the 240-280 stem-loop structure by gel retardation assay of NCp7 binding to the HIV-1 RNA transcript. No significant difference was found in NCp7 binding affinity to RNA 224-402 and RNA 224-402DEL (data not shown). However, both RNA transcripts had the NC binding site described by Sakagushi et al. (27) in their sequences. At the present time, experiments with shorter or mutated RNA transcripts are under way with gel retardation assays.

NC protein was reported to possess nucleic acid unwinding (41, 52) and renaturation (42) activities. Thus, RNA-RNA recognition would first occur via the autocomplementary G257CGCGC262 sequence to form the kissing complex, and then, once bound to this transient complex, NCp7 would open both stems of the complex to permit the formation of the double stranded dimer (Fig. 6). Both activities of the protein are required to explain a RNA dimerization specifically activated by NCp7, since no other proteins, at least those known for their nucleic acid-annealing activity, are able to promote this process (2, 26). As described previously (39), in the absence of the protein, conversion of D37 into D55 is only possible when the temperature is increased to above 55 °C. In contrast, at 37 °C, NCp7 alone is capable of overcoming this major energy barrier and converting the kissing complex into the stable dimer. In light of these findings, we can propose the model described in Fig. 6.

As already reported, an autocomplementary sequence located in the loop of such a stem-loop structure has already been found downstream from the PBS of several other retroviral RNA genomes (36, 53).2 This strongly supports the concept that all retroviruses could have the involvement of this RNA structure in their dimerization process in common. If this were true, NC proteins of other retroviruses could be proposed as having the same mechanism of action as NCp7 does on HIV-1Lai RNA dimerization. Girard et al. (54) have just reported that NCp10 activates in vitro dimerization of Moloney murine leukemia virus RNA transcripts, which contain the autocomplementary stem-loop structure 283-298. Furthermore, the nucleocapsid proteins of various species could be exchangeable for this process, since NCp10 of Moloney murine leukemia virus and NCp12 of Rous sarcoma virus are capable of promoting HIV-1 RNA dimerization in vitro (2).

It has been suggested that the dimerization and encapsidation processes are linked, since encapsidation of the retroviral genome is governed by specific interactions between the NC domain of gag and the encapsidation-dimerization sequence (for review, see Ref. 3). It is noteworthy that the 240-280 stem-loop structure is located within the 5'-RNA-packaging signal of HIV-1 described recently by Clever et al. (40). Given our model, an appealing concept is that the NC protein could be a link between dimerization and encapsidation via the 240-280 RNA stem-loop structure. This structure could be a site for NC binding, among others described (2, 17, 18, 27), and perhaps a determinant for the encapsidation signal.

Our results also suggest that NCp7 may control HIV-1 RNA dimer maturation, and this would extend the role of the NC protein in vitro to one of its functions in the retroviral life cycle. Indeed, it has been reported that the genomic RNA dimer appears to be initially encapsidated in an extended conformation and then adopts a condensed structure (34, 3, and references therein). The authors suggested that dimeric RNA of HIV-1 (34) undergoes a change in conformation, which they termed a maturation event, after releasing the virus from the cell. Such a RNA maturation step would correlate with the cleavage of Gag precursor molecules by the viral protease and therefore with the presence of the processed nucleocapsid protein (34). The same authors found that an immature dimeric RNA isolated from protease-negative mutant virions dissociates into monomers at a lower temperature than the mature wild-type dimer. It has also been reported that the linkage between subunits of B77 sarcoma virus RNA is stabilized as a function of time during extracellular virion maturation (48). In this case, RNA monomers are linked by unstable base pair regions in the immature dimer, which are disrupted during RNA phenol extraction. This observation is reminiscent of that found with the kissing complex, an unstable dimer that dissociates after SDS-phenol treatment and could correspond to such an immature dimer. These results are consistent with our in vitro model of the HIV-1 RNA dimerization process. In the absence of the protein, the HIV-1 RNA transcript forms an unstable dimer, namely the one that totally dissociates at room temperature during phenol extraction (Fig. 2B). Under the effect of NCp7, this dimer then undergoes a change in conformation to become more stable (Fig. 3). This change can be considered the first step of the dimer maturation event if indeed this step corresponds to a stabilization of the 240-280-base pair region (Fig. 6). In this manner, NCp7 would also promote the stabilization of other RNA-RNA interactions occurring along the genomic RNA, which certainly exist during nucleocapsid maturation, once the virus has been released from the cell. Our results lead to a simple model system in which the molecular and structural aspects of the RNA dimerization process and NCp7-mediated RNA maturation can be studied in detail.

However, when we propose that NCp7 plays the same role in vivo as in vitro, we should be aware that we cannot exclude the possibility that in vivo there may be some other accessory factors that could aid in the formation of this stable dimer.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported by a fellowship from the Agence Nationale de la Recherche sur le SIDA.
   To whom correspondence should be addressed.
1    The abbreviations used are: NCp, nucleocapsid protein; HIV, human immunodeficiency virus; Tm, melting temperature; nt, nucleotide; DEL, deletion.
2    P. Fossé, unpublished observations.

Acknowledgments

We thank Dr. P. Fossé (Institut Gustave Roussy) for helpful discussions and comments on the manuscript and L. Saint Ange (Institut Gustave Roussy) for editing the manuscript.


REFERENCES

  1. Coffin, J. M. (1984) in RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H., and Coffin, J., eds), Vol. 1, pp. 261-368, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  2. Darlix, J.-L., Gabus, C., Nugeyre, M.-T., Clavel, F., and Barré-Sinoussi, F. (1990) J. Mol. Biol. 216, 689-699 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  3. Darlix, J.-L., Lapadat-Tapolsky, M., de Rocquigny, H., and Roques, B. P. (1995) J. Mol. Biol. 254, 523-537 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  4. Dickson, C., Eisenman, R., Fan, H., Hunter, E., and Reich, N. (1985) in RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H., Coffin, J., eds) Part 2, pp. 513-648, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  5. Covey, S. N. (1986) Nucleic Acids Res. 14, 623-633 [Medline] [Abstract/Free Full Text]
  6. Mély, Y., Cornille, F., Fournié-Zaluski, M. C., Darlix, J.-L., Roques, B. P., and Gérard, D. (1991) Biopolymers 31, 899-906 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  7. Berg, J. (1986) Science 232, 485-487 [Medline] [Abstract/Free Full Text]
  8. South, T. L., and Summers, M. F. (1993) Protein Sci. 2, 3-19 [Medline] [Medline] [Order article via Infotrieve]
  9. Morellet, N., Jullian, N., De Rocquigny, H., Maigret, B., Darlix, J.-L., and Roques, B. P. (1992) EMBO J. 11, 3059-3065 [Medline] [Medline] [Order article via Infotrieve]
  10. Morellet, N., De Rocquigny, H., Mély, Y., Jullian, N., Déméné, H., Ottmann, M., Gérard, D., Darlix, J.-L., Fournié-Zaluski, M.-C., and Roques, B. P. (1994) J. Mol. Biol. 235, 287-301 [Medline] [Medline] [Order article via Infotrieve]
  11. Déméné, H., Dong, C. Z., Ottmann, M., Rouyez, M. C., Jullian, N., Morellet, N., Mély, Y., Darlix, J. L., Fournié-Zaluski, M. C., Saragosti, S., and Roques, B. P. (1994) Biochemistry 33, 11707-11716 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  12. Mély, Y., Jullian, N., Morellet, N., De Rocquigny, H., Dong, C. Z., Piemont, E., Roques, B. P., and Gérard, D. (1994) Biochemistry 33, 12085-12091 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  13. Méric, C., Gouilloud, E., and Spahr, P.-F. (1988) J. Virol. 62, 3328-3333 [Medline] [Abstract/Free Full Text]
  14. Aldovini, A., and Young, R. A. (1990) J. Virol. 64, 1920-1926 [Medline] [Abstract/Free Full Text]
  15. Gorelick, R. J., Nigida, S. M., Jr., Bess, J. W., Jr., Arthur, L. O., Henderson, L. E., and Rein, A. (1990) J. Virol. 64, 3207-3211 [Medline] [Abstract/Free Full Text]
  16. Ottmann, M., Gabus, C., and Darlix, J.-L. (1995) J. Virol. 69, 1778-1784 [Medline] [Abstract]
  17. Berkowitz, R. D., Ohagen, A., Höglund, S., and Goff, S. P. (1995) J. Virol. 69, 6445-6456 [Medline] [Abstract]
  18. Dannull, J., Surovoy, A., Jung, G., and Moelling, K. (1994) EMBO J. 13, 1525-1533 [Medline] [Medline] [Order article via Infotrieve]
  19. Prats, A.-C., Sarih, L., Gabus, C., Litvak, S., Keith, G., and Darlix, J.-L. (1988) EMBO J. 7, 1777-1783 [Medline] [Medline] [Order article via Infotrieve]
  20. Barat, C., Lullien, V., Schatz, O., Keith, G., Nugeyre, M. T., Grüninger-Leitch, F., Barré-Sinoussi, F., Le Grice, S. F. J., and Darlix, J.-L. (1989) EMBO J. 8, 3279-3285 [Medline] [Medline] [Order article via Infotrieve]
  21. De Rocquigny, H., Gabus, C., Vincent, A., Fournié-Zaluski, M.-C., Roques, B., and Darlix, J.-L. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6472-6476 [Medline] [Abstract/Free Full Text]
  22. Darlix, J.-L., Vincent, A., Gabus, C., De Rocquigny, H., and Roques, B. (1993) C. R. Acad. Sci. Paris 316, 763-771 [Medline]
  23. Lapadat-Tapolsky, M., De Rocquigny, H., Van Gent, D., Roques, B., Plasterk, R., and Darlix, J.-L. (1993) Nucleic Acids Res. 21, 831-839 [Medline] [Abstract/Free Full Text]
  24. You, J. C., and McHenry, C. S. (1994) J. Biol. Chem. 269, 31491-31495 [Medline] [Abstract/Free Full Text]
  25. Tsuchihashi, Z., and Brown, P. O. (1994) J. Virol. 68, 5863-5870 [Medline] [Abstract/Free Full Text]
  26. Lapadat-Tapolsky, M., Pernelle, C., Borie, C., and Darlix, J.-L. (1995) Nucleic Acids Res. 23, 2434-2441 [Medline] [Abstract/Free Full Text]
  27. Sakagushi, K., Zambrano, N., Baldwin, E. T., Shapiro, B. A., Erickson, J. E., Omichinski, J. G., Clore, G. M., Gronenborn, A. M., and Appela, E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5219-5223 [Abstract/Free Full Text]
  28. Bender, W., Chien, Y. H., Chattopadkyay, S., Vogt, P. K., Gardner, M. R., and Davidson, N. (1978) J. Virol. 25, 888-896 [Medline] [Abstract/Free Full Text]
  29. Murti, K. G., Bondurant, M., and Tereba, A. (1981) J. Virol. 37, 411-419 [Medline] [Abstract/Free Full Text]
  30. Marquet, R., Baudin, F., Gabus, C., Darlix, J. L., Mougel, M., Ehresmann, C., and Ehresmann, B. (1991) Nucleic Acids Res. 18, 2349-2357
  31. Awang, G., and Sen, D. (1993) Biochemistry 32, 11453-11457 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  32. Sundquist, W., and Heaphy, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3393-3397 [Medline] [Abstract/Free Full Text]
  33. Berkout, B., Oude Essink, B. B., and Schoneveld, I. (1993) FASEB J. 7, 181-187 [Abstract]
  34. Fu, W., Gorelick, R. J., and Rein, A. (1994) J. Virol. 68, 5013-5018 [Medline] [Abstract/Free Full Text]
  35. Muriaux, D., Girard, P.-M., Bonnet-Mathonière, B., and Paoletti, J. (1995) J. Biol. Chem. 270, 8209-8216 [JBC][Medline] [Abstract/Free Full Text]
  36. Girard, P.-M., Bonnet-Mathonière, B., Muriaux, D., and Paoletti, J. (1995) Biochemistry 34, 9785-9794 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  37. Skripkin, E., Paillart, J. C., Marquet, R., Ehresmann, B., and Ehresmann, C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4945-4949 [Medline] [Abstract/Free Full Text]
  38. Laughrea, M., and Jetté, L. (1994) Biochemistry 33, 13464-13474 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  39. Muriaux, D., Fossé, P., and Paoletti, J. (1996) Biochemistry 35, 5075-5082 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  40. Clever, J., Sassetti, C., and Parslow, T. G. (1995) J. Virol. 69, 2101-2109 [Medline] [Abstract]
  41. Khan, R., and Giedroc, D. P. (1992) J. Biol. Chem. 267, 6689-6695 [Medline] [Abstract/Free Full Text]
  42. Dib-Hajj, F., Khan, R., and Giedroc, D. P. (1993) Protein Sci. 2, 231-243 [Medline] [Medline] [Order article via Infotrieve]
  43. De Rocquigny, H., Ficheux, D., Gabus, C., Fournié-Zaluski, M.-C., Darlix, J.-L., and Roques, B. (1991) Biochem. Biophys. Res. Commun. 180, 1010-1018 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  44. Zucker, M. (1989) Science 244, 48-52 [Abstract/Free Full Text]
  45. Turner, D. H., Sugimoto, N., and Freier, S. M. (1988) Annu. Rev. Biophys. Biophys. Chem. 17, 167-192 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  46. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  47. Massie, H. R., and Zimm, B. H. (1965) Proc. Natl. Acad. Sci. U. S. A. 54, 1641-1643 [Free Full Text]
  48. Stoltzfus, C. M., and Snyder, P. N. (1975) J. Virol. 16, 1161-1170 [Medline] [Abstract/Free Full Text]
  49. Laughrea, M., and Jetté, L. (1996) Biochemistry 35, 1589-1598 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  50. Egushi, Y., and Tomizawa, J. (1990) Cell 60, 199-209 [CrossRef][Medline] [Order article via Infotrieve]
  51. Predki, P. F., Nayak, L. M., Gottlieb, M. B. C., and Regan, L. (1995) Cell 80, 41-50 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  52. Priel, E., Aflalo, E., Seri, I., Henderson, L. E., Arthur, L. O., Aboud, M., Segal, S., and Blair, D. G. (1995) FEBS Lett. 362, 59-64 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  53. Feng, Y., Fu, W., Winter, A. J., Levin, J. G., and Rein, A. (1995) J. Virol. 69, 2486-2490 [Medline] [Abstract]
  54. Girard, P.-M., de Rocquigny, H., Roques, B., and Paoletti, J. (1996) Biochemistry 35, 8705-8714 [Medline] [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. Bernacchi, S. Freisz, C. Maechling, B. Spiess, R. Marquet, P. Dumas, and E. Ennifar
Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion
Nucleic Acids Res., December 18, 2007; 35(21): 7128 - 7139.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
L. Sinck, D. Richer, J. Howard, M. Alexander, D. F.J. Purcell, R. Marquet, and J.-C. Paillart
In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs
RNA, December 1, 2007; 13(12): 2141 - 2150.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
T. T. Baig, J.-M. Lanchy, and J. S. Lodmell
HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro
RNA, August 1, 2007; 13(8): 1341 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Henriet, L. Sinck, G. Bec, R. J. Gorelick, R. Marquet, and J.-C. Paillart
Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription
Nucleic Acids Res., August 1, 2007; 35(15): 5141 - 5153.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. D. Moore, W. Fu, O. Nikolaitchik, J. Chen, R. G. Ptak, and W.-S. Hu
Dimer Initiation Signal of Human Immunodeficiency Virus Type 1: Its Role in Partner Selection during RNA Copackaging and Its Effects on Recombination
J. Virol., April 15, 2007; 81(8): 4002 - 4011.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Mujeeb, N. B. Ulyanov, S. Georgantis, I. Smirnov, J. Chung, T. G. Parslow, and T. L. James
Nucleocapsid protein-mediated maturation of dimer initiation complex of full-length SL1 stemloop of HIV-1: sequence effects and mechanism of RNA refolding
Nucleic Acids Res., March 19, 2007; 35(6): 2026 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
X. Sun, Q. Zhang, and H. M. Al-Hashimi
Resolving fast and slow motions in the internal loop containing stem-loop 1 of HIV-1 that are modulated by Mg2+ binding: role in the kissing-duplex structural transition
Nucleic Acids Res., March 12, 2007; 35(5): 1698 - 1713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bernacchi, E. Ennifar, K. Toth, P. Walter, J. Langowski, and P. Dumas
Mechanism of Hairpin-Duplex Conversion for the HIV-1 Dimerization Initiation Site
J. Biol. Chem., December 2, 2005; 280(48): 40112 - 40121.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. S. Hibbert and A. Rein
Preliminary Physical Mapping of RNA-RNA Linkages in the Genomic RNA of Moloney Murine Leukemia Virus
J. Virol., July 1, 2005; 79(13): 8142 - 8148.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Buxton, G. Tachedjian, and J. Mak
Analysis of the Contribution of Reverse Transcriptase and Integrase Proteins to Retroviral RNA Dimer Conformation
J. Virol., May 15, 2005; 79(10): 6338 - 6348.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Muriaux, S. Costes, K. Nagashima, J. Mirro, E. Cho, S. Lockett, and A. Rein
Role of Murine Leukemia Virus Nucleocapsid Protein in Virus Assembly
J. Virol., November 15, 2004; 78(22): 12378 - 12385.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. S. Hibbert, J. Mirro, and A. Rein
mRNA Molecules Containing Murine Leukemia Virus Packaging Signals Are Encapsidated as Dimers
J. Virol., October 15, 2004; 78(20): 10927 - 10938.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Andersen, S. A. Contera, B. Knudsen, C. K. Damgaard, F. Besenbacher, and J. Kjems
Role of the Trans-activation Response Element in Dimerization of HIV-1 RNA
J. Biol. Chem., May 21, 2004; 279(21): 22243 - 22249.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Cristofari, R. Ivanyi-Nagy, C. Gabus, S. Boulant, J.-P. Lavergne, F. Penin, and J.-L. Darlix
The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro
Nucleic Acids Res., May 11, 2004; 32(8): 2623 - 2631.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-R. Mihailescu and J. P. Marino
A proton-coupled dynamic conformational switch in the HIV-1 dimerization initiation site kissing complex
PNAS, February 3, 2004; 101(5): 1189 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Oshima, D. Muriaux, J. Mirro, K. Nagashima, K. Dryden, M. Yeager, and A. Rein
Effects of Blocking Individual Maturation Cleavages in Murine Leukemia Virus Gag
J. Virol., February 1, 2004; 78(3): 1411 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. Windbichler, M. Werner, and R. Schroeder
Kissing complex-mediated dimerisation of HIV-1 RNA: coupling extended duplex formation to ribozyme cleavage
Nucleic Acids Res., November 15, 2003; 31(22): 6419 - 6427.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Gubbins, D. C. Arthur, A. F. Ghetu, J. N. M. Glover, and L. S. Frost
Characterizing the Structural Features of RNA/RNA Interactions of the F-plasmid FinOP Fertility Inhibition System
J. Biol. Chem., July 18, 2003; 278(30): 27663 - 27671.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. Ennifar, P. Walter, and P. Dumas
A crystallographic study of the binding of 13 metal ions to two related RNA duplexes
Nucleic Acids Res., May 15, 2003; 31(10): 2671 - 2682.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Balakrishnan, B. P. Roques, P. J. Fay, and R. A. Bambara
Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis
J. Virol., April 15, 2003; 77(8): 4710 - 4721.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. S. Andersen, R. E. Jeeninga, C. K. Damgaard, B. Berkhout, and J. Kjems
Dimerization and Template Switching in the 5' Untranslated Region between Various Subtypes of Human Immunodeficiency Virus Type 1
J. Virol., March 1, 2003; 77(5): 3020 - 3030.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Ennifar, J.-C. Paillart, R. Marquet, B. Ehresmann, C. Ehresmann, P. Dumas, and P. Walter
HIV-1 RNA Dimerization Initiation Site Is Structurally Similar to the Ribosomal A Site and Binds Aminoglycoside Antibiotics
J. Biol. Chem., January 17, 2003; 278(4): 2723 - 2730.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. M. G. Dirac, H. Huthoff, J. Kjems, and B. Berkhout
Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
J. Gen. Virol., October 1, 2002; 83(10): 2533 - 2542.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hoeprich and P. Guo
Computer Modeling of Three-dimensional Structure of DNA-packaging RNA (pRNA) Monomer, Dimer, and Hexamer of Phi29 DNA Packaging Motor
J. Biol. Chem., May 31, 2002; 277(23): 20794 - 20803.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Shehu-Xhilaga, M. Hill, J. A. Marshall, J. Kappes, S. M. Crowe, and J. Mak
The Conformation of the Mature Dimeric Human Immunodeficiency Virus Type 1 RNA Genome Requires Packaging of Pol Protein
J. Virol., March 27, 2002; 76(9): 4331 - 4340.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Ly and T. G. Parslow
Bipartite Signal for Genomic RNA Dimerization in Moloney Murine Leukemia Virus
J. Virol., March 7, 2002; 76(7): 3135 - 3144.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Shehu-Xhilaga, H. G. Kraeusslich, S. Pettit, R. Swanstrom, J. Y. Lee, J. A. Marshall, S. M. Crowe, and J. Mak
Proteolytic Processing of the P2/Nucleocapsid Cleavage Site Is Critical for Human Immunodeficiency Virus Type 1 RNA Dimer Maturation
J. Virol., October 1, 2001; 75(19): 9156 - 9164.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-X. Feng, S. P. Moore, D. J. Garfinkel, and A. Rein
The Genomic RNA in Ty1 Virus-Like Particles Is Dimeric
J. Virol., November 15, 2000; 74(22): 10819 - 10821.
[Abstract] [Full Text]


Home page
J. Virol.Home page
R. J. Gorelick, W. Fu, T. D. Gagliardi, W. J. Bosche, A. Rein, L. E. Henderson, and L. O. Arthur
Characterization of the Block in Replication of Nucleocapsid Protein Zinc Finger Mutants from Moloney Murine Leukemia Virus
J. Virol., October 1, 1999; 73(10): 8185 - 8195.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. A. Ortiz-Conde and S. H. Hughes
Studies of the Genomic RNA of Leukosis Viruses: Implications for RNA Dimerization
J. Virol., September 1, 1999; 73(9): 7165 - 7174.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Jossinet, J. S. Lodmell, C. Ehresmann, B. Ehresmann, and R. Marquet
Identification of the in Vitro HIV-2/SIV RNA Dimerization Site Reveals Striking Differences with HIV-1
J. Biol. Chem., February 16, 2001; 276(8): 5598 - 5604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. G. Dirac, H. Huthoff, J. Kjems, and B. Berkhout
The Dimer Initiation Site Hairpin Mediates Dimerization of the Human Immunodeficiency Virus, Type 2 RNA Genome
J. Biol. Chem., August 17, 2001; 276(34): 32345 - 32352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Takahashi, S. Baba, Y. Koyanagi, N. Yamamoto, H. Takaku, and G. Kawai
Two Basic Regions of NCp7 Are Sufficient for Conformational Conversion of HIV-1 Dimerization Initiation Site from Kissing-loop Dimer to Extended-duplex Dimer
J. Biol. Chem., August 10, 2001; 276(33): 31274 - 31278.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muriaux, D.
Right arrow Articles by Paoletti, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muriaux, D.
Right arrow Articles by Paoletti, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement